Mr. Angotti was appointed chief executive officer and a member of the company's board of directors in March 2017.
Mr. Angotti brings over two decades of experience leading executive and commercial teams at public and private life sciences companies, most recently as CEO of XenoPort, Inc., a biopharmaceutical company focused on the development of treatments for neuropathic pain and other neurological disorders.
During his tenure at XenoPort, Mr. Angotti was involved in the re-acquisition of Horizant from GSK and implemented a successful re-branding and re-launch strategy leading to XenoPort's acquisition by Arbor Pharmaceuticals, LLC in 2016.
Previous to joining XenoPort, Mr. Angotti held senior sales and marketing positions at Reliant Pharmaceuticals, Inc. from 2001 – 2008. In his role as senior vice president of sales and marketing at Reliant, Mr. Angotti was integrally involved in the company's M&A discussions that concluded with Reliant's acquisition by GSK in 2007. Mr. Angotti began his career in the life sciences industry at Novartis Pharmaceuticals Corp., where he worked from 1991 – 2001 in sales and operations positions of increasing responsibility.
Mr. Angotti earned a Bachelor of Science with a concentration in business management from Cornell University in 1990 and a Master of Business Administration with honors in 2000 from Columbia University.
What is Vincent J. Angotti's net worth?
The estimated net worth of Vincent J. Angotti is at least $932.82 thousand as of March 13th, 2026. Mr. Angotti owns 800,705 shares of Talphera stock worth more than $932,821 as of September 23rd. This net worth evaluation does not reflect any other investments that Mr. Angotti may own. Learn More about Vincent J. Angotti's net worth.
How do I contact Vincent J. Angotti?
Has Vincent J. Angotti been buying or selling shares of Talphera?
Vincent J. Angotti has not been actively trading shares of Talphera within the last three months. Most recently, on Friday, March 13th, Vincent J. Angotti bought 213,310 shares of Talphera stock. The stock was acquired at an average cost of $0.59 per share, with a total value of $125,852.90. Following the completion of the transaction, the chief executive officer now directly owns 800,705 shares of the company's stock, valued at $472,415.95. Learn More on Vincent J. Angotti's trading history.
Who are Talphera's active insiders?
Are insiders buying or selling shares of Talphera?
In the last year, Talphera insiders bought shares 5 times. They purchased a total of 433,674 shares worth more than $304,347.74. The most recent insider tranaction occured on March, 13th when CEO
Vincent J. Angotti bought 213,310 shares worth more than $125,852.90. Insiders at Talphera own 3.5% of the company.
Learn More about insider trades at Talphera. Information on this page was last updated on 3/13/2026.
